Terumo Buying Organ Tech Provider OrganOx for $1.5 Billion Terumo Corp. has agreed to buy UK-based organ medical tech company OrganOx Ltd. in a deal valued at around $1.5 billion, seeking entry into the organ transplant field. Related Posts:ServiceNow Nears Up to $7 Billion Deal for ArmisNovartis Agrees to Buy Avidity in $12 Billion Biotech DealSoftBank Makes Surprise $2 Billion Bet on Intel’s AI RevivalQualtrics Agrees to Buy Press Ganey Forsta in $6.75…Vistra Makes AI Power Bet With $1.9 Billion Gas DealCoforge Buys Encora at $2.35 Billion EV in All-Stock DealSee also AI Boom Is Triggering a Loan Meltdown for Software Companies: Credit Weekly